NFKB1 and lung cancer: In lung cancer and chronic obstructive pulmonary disease (COPD), the NF-κB pathway is linked to the inflammatory signaling, oxidative stress response, and glycolysis and gluconeogenesis pathways, as revealed by proteomic analyses [9].